Biosimilars in den deutschen Biologika-Registern RABBIT und RABBIT-SpA

Using advanced epidemiological methods, Programme Area 2 investigates biological, psychosocial and health care-related factors that influence the course and outcome of rheumatic diseases in adults and children. Our research mainly builds on long-term observational studies, conducted in close cooperation with a nationwide network of more than 500 paediatric and adult rheumatology specialists. In addition, specific population-based analyses are carried out using data from health insurance companies ...

The RABBIT-SpA disease register, established in May 2017, aims to investigate the long-term effectiveness and safety of therapies used in spondyloarthritis. Data from rheumatologists and patients on disease progression, treatment, therapy outcomes, and therapy safety are collected to gain a better understanding of the different treatment approaches. Aspects related to quality of life, mental health, and work ability are also the focus of our analyses. The web-based documentation system was developed ...